Photo taken from cancercenter.com
Jul 24, 2024, 22:22
Nelson Dusetti: One of the first publications from the Franco-Argentine Network for Pancreatic Cancer
“We are thrilled to announce one of the first publications from the Franco-Argentine Network for Pancreatic Cancer advancing global research on this malignancy.
This study identifies the ABCC4/MRP4 transporter as a crucial factor in pancreatic cancer aggressiveness and metastasis. ABCC4 promotes epithelial-mesenchymal transition (EMT), enhancing cell motility and chemoresistance. High ABCC4 levels correlate with EMT markers, making it a valuable prognostic marker and a potential therapeutic target, particularly for aggressive basal-like/squamous PDAC subtypes.“
A
The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer published in Frontiers
Autors:
Source: /LinkedIn
Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.”
A. Sahores
A. Yaneff
B. González
C. A. Davio
C. Shayo
cancer
Cancer research
epithelial-mesenchymal transition (EMT)
Franco-Argentine Network for Pancreatic Cancer
Frontiers
J. Iovanna
M. G. de Sousa Serro
M. May
N. Di Siervi
N. Fraunhoffer
N. Gómez
Nelson Dusetti.
OncoDaily
Oncology
Pancreatic Cancer
S. N. Gancedo
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 22, 2024, 12:50
Nov 22, 2024, 12:45
Nov 22, 2024, 12:39
Nov 22, 2024, 12:04
Nov 22, 2024, 11:40
Nov 22, 2024, 11:39
Nov 22, 2024, 11:35